Inspiring science? Check ✅ Fueling progress? Check ✅ Revolutionizing care? Check ✅ Bonum team members Justin Killebrew, Ph.D., Diane Hollenbaugh, Ph.D., Shannon Okada, and John Mulligan, Ph.D. enjoyed sharing data on our lead candidate, cLAG3-IL2, and learning about the latest advances in cancer science and medicine at #AACR24! Thanks to the American Association for Cancer Research for hosting yet another informative annual meeting. Next Up: #KSAntibodyEng24 in Breckenridge, CO, May 5-8, 2024
Bonum Therapeutics’ Post
More Relevant Posts
-
Dr. Paul Davies of The Beyond Center for Fundamental Concepts in Science at ASU and Arizona State University joins our Aug. 31 #InsightsForum to discuss how dysregulated information drives dysfunctional communication within and across biological scales in cancer. Don’t miss this important conversation and RSVP now ➡️ eirf.org/insights #CancerResearch #Insights #EllisonInstitute
To view or add a comment, sign in
-
-
Thanks to Milana Madzarac for writing this great article!
#WaterlooPharmacy MSc student Norman Ly won the University of Waterloo 2024 GRADflix People’s Choice Award for his 'Immune system: How does cancer turn it off?' submission. Learn more about his research: https://bit.ly/4abRghc @university of waterloo faculty of science
To view or add a comment, sign in
-
-
Scott Gottlieb and Lauren Silvis are discussing the importance of regulatory frameworks and policy to support innovative test development live at Friends of Cancer Research's Public Meeting. Watch here: https://lnkd.in/e5RewcRn #AIOncology #FriendsDX #HRDFriends
To view or add a comment, sign in
-
-
Next Thursday Feb 1, Jeff Shuren, Scott Gottlieb & Lauren Silvis, will discuss the importance of regulatory frameworks & policy to support innovative test development during Friends of Cancer Research's Public Meeting. Register here: bit.ly/3t7MYZ3 #FriendsDx
To view or add a comment, sign in
-
-
"Between 1989 and 1993, inclusion of women in clinical research was NIH policy, but it was not law. In 1993, Congress wrote the NIH inclusion policy into Federal law through a section in the NIH Revitalization Act of 1993 (Public Law 103-43) titled Women and Minorities as Subjects in Clinical Research. 10 The law includes various requirements for NIH-funded research, including the following: *NIH ensures that women and minorities are included in all clinical research. *In trials including women and minorities, the trial should be designed and carried out so that it is possible to analyze whether the variables being studied affect women and minorities differently than other participants. *Cost is not an acceptable reason for excluding women and minorities. *NIH initiates programs and support for outreach efforts to recruit and retain women and minorities and their subpopulations as volunteers in clinical studies." - NIH I was already 20 when women were just starting to be considered for clinical trials...! We (Stack ) are getting there; training and upskilling the future of the clinical research workforce. https://bit.ly/4dPBY56 #womenshealth #clinicalresearch #diversity #workforcedevelopment
Happy Clinical Trials Day! “In the world of clinical research, the path forward is forged through the relentless pursuit of knowledge, an exacting application of best practices, and an unwavering commitment to championing patient well-being. This is the work of clinical research professionals. They Are the Trailblazers Among Us.” - ACRP - Association of Clinical Research Professionals We couldn't agree more! We ❤️ Chavonne Dunbar from Dana-Farber Cancer Institute and all our Stack Alums: https://bit.ly/3K7mls7 #ClinicalTrialsDay #CTD2024
To view or add a comment, sign in
-
-
Join the Omega Education Team for a webinar on February 28, from 12:00 pm to 1:00 pm EST, titled 'Tumor Talk: What's New in 2024,' presented by our Cancer Registry expert, Janet Vogel as she explores and highlights some of the new challenges of abstracting medical data in 2024, utilizing various case scenarios. Register Now: https://lnkd.in/guvKnRQx #TumorTalk #CancerResearch #MedicalCoding #CancerDataCuration #CancerData
To view or add a comment, sign in
-
-
At #HLTH2023 bumped into industry visionary, Medidata Co-Founder, and AI Cure CEO Edward Ikeguchi who if you noticed from his badge is now also launching Akyrian Systems, focused on what he calls "EDC at it's next level". In the early days of Medidata, Ed and I worked together to meet with the National Cancer Institute (NCI) and upgrade their ability to capture important research data for patients on NCI sponsored clinical trials. No doubt he has the vision to take "EDC to the next level"! DataArt
To view or add a comment, sign in
-
-
Did you know 15.1 million Americans are eligible for #lungcancerscreening, but fewer than 1 million get screened annually with a low-dose CT? That's less than 6%. Our Chief Executive Officer, Victor Velculescu, MD, PhD, had the pleasure of giving a Tech Talk at this year’s #HLTH2023 conference, spotlighting our approach to help detect cancer at population scale and the product that does it: FirstLook Test. See Victor’s 10-minute talk, from the science of fragmentomics and #machinelearning, to the process of FirstLook’s convenient blood test below.
A 'FirstLook' at DELFI's New Way to Help Detect Early Lung Cancer
https://www.youtube.com/
To view or add a comment, sign in
-
Clinical Trials Day, May 20 Today we celebrate the scientists, researchers, and healthcare professionals who make clinical trials possible. With deep gratitude, we honor every individual who has participated in these trials, contributing to medical advancements and a healthier future for all. Whether you are a participant, researcher, or sponsor, your participation is invaluable. Together at King Hussein Cancer Foundation and Center we are aiming for a brighter tomorrow. ACRP - Association of Clinical Research Professionals #ClinicalTrialsDay #CTD2024 #MedicalResearch #HealthcareInnovation #AdvancingMedicine
To view or add a comment, sign in
-
-
🔑 And this is it! 🎓 Today is the last Online Advanced Course on Biomedical Imaging session. Thanks to our excellent group of speakers, there have been 12 sessions with an enriching exchange of knowledge and information. 🌱 To finish on a high note, in today's session, we will look at Radiobiology with the help of MD Anderson Cancer Center researchers. Get to know them: 👉 Gabriel Sawakuchi | MD Anderson 👉 Scott Bright | MD Anderson 👉 Poliana Marinello | MD Anderson #biomedicalimaging #training
To view or add a comment, sign in
-
More from this author
-
The Business of Biotech Highlights Bonum CEO John Mulligan & CBO Neela Patel
Bonum Therapeutics 7mo -
A BD Checklist: Best Practices for Partnering with Pharma - by Neela Patel
Bonum Therapeutics 9mo -
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics - by Justin Killebrew
Bonum Therapeutics 1y